8-K: 180 Life Sciences Corp. Implements 1-for-19 Reverse Stock Split to Regain NASDAQ Compliance

180 Life Sciences Corp. has executed a 1-for-19 reverse stock split to meet the NASDAQ's minimum bid price requirement, effective February 28, 2024.

Summary

• 180 Life Sciences Corp. has completed a 1-for-19 reverse stock split of its common stock.
• The reverse stock split was approved by stockholders on February 16, 2024, and the board of directors also approved the 1-for-19 ratio on the same day.
• The reverse stock split became effective on February 28, 2024, at 12:01 a.m. Eastern Time.
• The company's common stock is expected to begin trading on a post-split basis on February 28, 2024, with a new CUSIP number: 68236V302.
• The total outstanding shares of common stock will be reduced from approximately 11.3 million to approximately 0.6 million.
• No fractional shares will be issued; instead, fractional shares will be rounded up to the nearest whole share.
• The reverse stock split is intended to increase the company's stock price to meet the NASDAQ's minimum bid price requirement of $1.00 per share.

Sentiment

Score: 5

Explanation: The document is neutral in tone, detailing a necessary action to maintain listing compliance. While the reverse stock split is a negative indicator of past performance, it is a necessary step for the company's future.

Positives

• The reverse stock split is expected to bring the company into compliance with NASDAQ's minimum bid price requirement.
• The company's existing registration statements are automatically amended to reflect the reduced number of shares.
• The reverse stock split does not alter the par value of the common stock or modify any voting rights.

Negatives

• The reverse stock split was necessary due to the company's stock price falling below the NASDAQ's minimum bid price requirement.
• The reverse stock split reduces the number of outstanding shares, which may be perceived negatively by some investors.

Risks

• The company's stock price must remain above $1.00 for a minimum of 10 consecutive business days to maintain compliance with NASDAQ listing rules.
• There is no guarantee that the reverse stock split will permanently increase the stock price above the required minimum.
• The company received a deficiency letter from NASDAQ on September 7, 2023, indicating non-compliance with the minimum bid price requirement.

Future Outlook

The company expects that the reverse stock split will increase the closing bid price of its common stock above the $1.00 per share requirement, allowing it to maintain its listing on the NASDAQ Capital Market.

Management Comments

• The company is effecting the Reverse Stock Split to satisfy the $1.00 minimum bid price requirement, as set forth in Nasdaq Listing Rule 5550(a)(2), for continued listing on The NASDAQ Capital Market.

Industry Context

Reverse stock splits are a common strategy for companies facing delisting from major exchanges due to low stock prices. This action is often a last resort to regain compliance and maintain access to capital markets.

Comparison to Industry Standards

• Many companies facing similar delisting threats have implemented reverse stock splits, including companies in the biotechnology and pharmaceutical sectors.
• The 1-for-19 ratio is within the typical range for reverse stock splits, which can vary widely depending on the company's specific circumstances and the desired post-split stock price.
• Other companies that have recently undertaken reverse stock splits include [hypothetical company A] with a 1-for-10 split and [hypothetical company B] with a 1-for-20 split, demonstrating the range of ratios used.

Stakeholder Impact

• Shareholders will see a reduction in the number of shares they own, but their percentage ownership will remain virtually unchanged.
• The reverse stock split is intended to benefit shareholders by maintaining the company's listing on the NASDAQ.
• Employees may be impacted by the change in share price and the company's overall financial health.

Next Steps

• The company's stock will begin trading on a post-split basis on February 28, 2024.
• The company must maintain a stock price above $1.00 for at least 10 consecutive business days to regain full compliance with NASDAQ listing rules.

Key Dates

Keywords

reverse stock split, NASDAQ compliance, minimum bid price, stock price, common stock, share reduction, ATNF, ATNFW